SpringWorks Therapeutics Inc

NASDAQ:SWTX  
74.81
+1.97 (+2.70%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

SpringWorks Therapeutics Inc Stock, NASDAQ:SWTX

100 Washington Boulevard, Stamford, Connecticut 06902
United States of America
Phone: +1.203.883.9490
Number of Employees: 78

Description

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in applying a precision medicine approach to acquiring, developing and commercializing medicines. It focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer. Its pipeline include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.